Table 2.
Frequencies of leprosy patients by CF, type of leprosy reactions, and positivity for salivary anti-lipoarabinomannan (LAM) sIgA, followed by odds ratios (OR), confidence interval at 95% (CI95%), and probability levels (P) toward the occurrence of reactions.
| CF | n | Anti-LAM sIgA | Total, n(%) | Reaction (n) |
Total (n) |
OR | Confidence interval (95%) | P | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| T1 | T2 | M | R | No | |||||||
| TT | 8 | + | 4 (50) | 2 | 0 | 0 | 2 | 2 | 9.00 | 0.29–271.67 | 0.20 |
| − | 4 (50) | 0 | 0 | 0 | 0 | 4 | |||||
| BT | 58 | + | 33 (56.9) | 16 | 0 | 0 | 16 | 17 | 6.90a | 1.72–27.60 | 0.006 |
| − | 25 (43.1) | 3 | 0 | 0 | 3 | 22 | |||||
| BB | 11 | + | 7 (63.6) | 3 | 0 | 0 | 3 | 4 | 0.08 | 0.003–2.20 | 0.138 |
| − | 4 (36.4) | 4 | 0 | 0 | 4 | 0 | |||||
| BL | 17 | + | 10 (58.8) | 2 | 1 | 3 | 6 | 4 | 1.12 | 0.15–7.98 | 0.906 |
| − | 7 (41.2) | 3 | 0 | 1 | 4 | 3 | |||||
| LL | 19 | + | 12 (63.2) | 0 | 6 | 1 | 7 | 5 | 1.05 | 0.15–6.92 | 0.959 |
| − | 7 (36.8) | 0 | 4 | 0 | 4 | 3 | |||||
| Total | 116 | 33 | 11 | 5 | 49 | 67 | |||||
Bold fonts were used to emphasize the significant values.
aStatistically significant.
CF, clinical form; TT, tuberculoid; BT, borderline-tuberculoid; BB, borderline–borderline; BL, borderline-lepromatous; LL, lepromatous.
Reaction (R): T1 = reaction type 1 (RR, reversal reaction); T2 = reaction type 2 (ENR, erythema nodosum reaction); M = mixed reaction (T1/T2); No = no reaction.